Addex Pharmaceuticals

Addex Pharmaceuticals (VTX:ADXN) Geneva, Switzerland, 12 November 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on November 11, 2008, S.R. One Ltd, the investment arm of GlaxoSmithKline plc, informed of reaching the threshold of 5.0% in the shareholding of Addex Pharmaceuticals Ltd. as the result of its acquisition in the market of shares. S.R. One said it had acquired a total of 293,125 registered shares, corresponding to 5.0% of the voting rights.

Addex Pharmaceuticals (SWF:ADXN) Français (PDF) Deutsch (PDF) English (PDF)

Addex Pharmaceuticals (SWF:ADXN) Geneva, Switzerland, 26 September 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on September 25, 2008, S.R. One Ltd, the investment arm of GlaxoSmithKline plc, has informed of reaching the threshold of 3.0% in the shareholding of Addex Pharmaceuticals Ltd., holding a total of 175,951 registered shares, corresponding to 3.0% of the voting rights.

Addex Pharmaceuticals (SWF:ADXN) * Second trial showing mGluR5 inhibition reduces reflux in humans * Side effects dramatically reduced by formulation * Twice-daily oral dosing achieved * Doses selected for Phase IIb trials * Phase IIb GERD and migraine trials to start in 4Q08

Addex Pharmaceuticals (SWF:ADXN) Geneva, Switzerland, 7 August 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on August 6, 2008, Varuma AG, Aeschenvorstadt 55, 4051 Basel, Switzerland, has informed of exceeding the threshold of 3% in the shareholding of Addex Pharmaceuticals Ltd., holding a total of 231,425 registered shares, corresponding to 3.95% of the voting rights. The beneficiary of the shareholdings of Varuma AG is Mr. Rudolf Maag, at Neuhofweg 11, 4102 Binningen, Switzerland.

Addex Pharmaceuticals (SWISS: ADXN) Geneva, Switzerland, 5 August 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on July 31, 2008, The Swiss Helvetia Fund, Inc. 1270 Avenue of the Americas, Suite 400, New York, NY 10020, U.S.A., has informed of exceeding the threshold of 5% in the shareholding of Addex Pharmaceuticals Ltd., holding a total of 314,860 registered shares, corresponding to 5.37% of the voting rights.

Addex Pharmaceuticals Français (PDF) Deutsch (PDF) English (PDF)

Addex Pharmaceuticals Français (PDF) Deutsch (PDF) English (PDF)

Addex Pharmaceuticals Geneva, Switzerland, 18 July 2008 - Addex Pharmaceuticals Ltd. (SWX:ADXN) will discuss its financial results for the first half of 2008 and give a pipeline update during a teleconference and webcast for investors, analysts and the media on Monday, July 28 at 16:00 CET.

Addex Pharmaceuticals New formulation of ADX10059 selected